Sutro Biopharma, Inc.
NASDAQ:STRO
4.38 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 69.268 | 47.254 | 30.414 | 206.152 | 4.96 | 125.298 | 22.02 | 11.593 |
| Short Term Investments
| 306.35 | 287.11 | 167.524 | 161.985 | 112.904 | 79.194 | 0 | 35.928 |
| Cash and Short Term Investments
| 375.618 | 302.344 | 197.938 | 368.137 | 117.864 | 204.492 | 22.02 | 47.521 |
| Net Receivables
| 36.078 | 7.122 | 12.454 | 5.559 | 6.298 | 2.489 | 1.624 | 0.577 |
| Inventory
| 0 | -11.667 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 9.846 | 11.667 | 8.123 | 4.486 | 4.406 | 2.965 | 1.985 | 1.59 |
| Total Current Assets
| 421.542 | 309.466 | 218.515 | 378.182 | 128.568 | 209.946 | 25.629 | 49.688 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 44.755 | 51.064 | 51.591 | 12.935 | 9.633 | 10.934 | 13.997 | 18.69 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 32.02 | 68.775 | 0.872 | 15.609 | 0.015 | 0.223 | 0.482 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.439 | 14.394 | 2.527 | 2.122 | 2.56 | 2.244 | 0.92 | 0.417 |
| Total Non-Current Assets
| 49.194 | 97.478 | 122.893 | 15.929 | 27.802 | 13.193 | 15.14 | 19.589 |
| Total Assets
| 470.736 | 406.944 | 341.408 | 394.111 | 156.37 | 223.139 | 40.769 | 69.277 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 9.44 | 32.822 | 11.327 | 5.544 | 5.584 | 3.061 | 2.902 | 3.394 |
| Short Term Debt
| 10.481 | 17.085 | 10.412 | 8.823 | 1 | 4.724 | 14.634 | 3.189 |
| Tax Payables
| 15.165 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 20.666 | 106.644 | 5.496 | 14.603 | 19.465 | 21.574 | 10.709 | 43.576 |
| Other Current Liabilities
| 53.159 | -17.085 | 14.501 | 0.627 | 6.918 | 7.064 | 3.711 | 0.022 |
| Total Current Liabilities
| 93.746 | 139.466 | 41.736 | 29.597 | 32.967 | 36.423 | 31.956 | 50.181 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 149.114 | 50.43 | 46.962 | 24.545 | 8.876 | 10 | 0 | 1.193 |
| Deferred Revenue Non-Current
| 53.379 | 89.885 | 0 | 6.1 | 16.195 | 44.599 | 13.159 | 5.858 |
| Deferred Tax Liabilities Non-Current
| 23.154 | 0 | 0 | 1.34 | 0.409 | 0.476 | 0 | -1.193 |
| Other Non-Current Liabilities
| 1.694 | -89.885 | 0.146 | 0.481 | 0.134 | 0.102 | 104.655 | 104.139 |
| Total Non-Current Liabilities
| 227.341 | 50.43 | 47.108 | 32.466 | 25.614 | 55.177 | 117.814 | 109.997 |
| Total Liabilities
| 321.087 | 189.896 | 88.844 | 62.063 | 58.581 | 91.6 | 149.77 | 160.178 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 223.139 | 102.505 | 102.505 |
| Common Stock
| 0.061 | 0.058 | 0.046 | 0.046 | 0.023 | 0.023 | 0 | 0.016 |
| Retained Earnings
| -559.408 | -452.615 | -333.411 | -227.873 | -195.745 | -150.328 | -115.011 | -95.323 |
| Accumulated Other Comprehensive Income/Loss
| 0.021 | -0.618 | -0.314 | 0.129 | 0.165 | -0.047 | -0.208 | -0.017 |
| Other Total Stockholders Equity
| 708.975 | 670.223 | 586.243 | 559.746 | 293.346 | 58.752 | -96.287 | -98.082 |
| Total Shareholders Equity
| 149.649 | 217.048 | 252.564 | 332.048 | 97.789 | 131.539 | -109.001 | -90.901 |
| Total Equity
| 149.649 | 217.048 | 252.564 | 332.048 | 97.789 | 131.539 | -109.001 | -90.901 |
| Total Liabilities & Shareholders Equity
| 470.736 | 406.944 | 341.408 | 394.111 | 156.37 | 223.139 | 40.769 | 69.277 |